The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Semiglazova T.Iu.

FGBU "NII onkologii im. N.N. Petrova" Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Semiglazov V.V.

N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia

Filatova L.V.

FGBU "NII onkologii im. N.N. Petrova" Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Krivorot'ko P.V.

FGBU "NII onkologii im. N.N. Petrova" Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Paltuev R.M.

FGBU "NII onkologii im. N.N. Petrova" Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Latipova D.Kh.

FGBU "NII onkologii im. N.N. Petrova" Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Gershanovich M.L.

FGBU "NII onkologii im. N.N. Petrova" Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Metastatic breast cancer: Innovation targeted agents

Authors:

Semiglazova T.Iu., Semiglazov V.V., Filatova L.V., Krivorot'ko P.V., Paltuev R.M., Latipova D.Kh., Gershanovich M.L.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2012;1(2): 94‑99

Views: 3357

Downloaded: 62


To cite this article:

Semiglazova TIu, Semiglazov VV, Filatova LV, Krivorot'ko PV, Paltuev RM, Latipova DKh, Gershanovich ML. Metastatic breast cancer: Innovation targeted agents. P.A. Herzen Journal of Oncology. 2012;1(2):94‑99. (In Russ.)

Recommended articles:

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.